165 related articles for article (PubMed ID: 21805106)
1. Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy.
Manjaly JG; Vaughan-Shaw PG; Dale OT; Tyler S; Corlett JC; Frost RA
Dysphagia; 2012 Jun; 27(2):216-20. PubMed ID: 21805106
[TBL] [Abstract][Full Text] [Related]
2. A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD).
Waito AA; Steele CM; Peladeau-Pigeon M; Genge A; Argov Z
Dysphagia; 2018 Dec; 33(6):789-802. PubMed ID: 29725764
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis.
Witting N; Daugaard D; Prytz S; Biernat H; Diederichsen LP; Vissing J
J Neurol; 2022 Aug; 269(8):4154-4160. PubMed ID: 35244767
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy.
Tabor LC; Plowman EK; Romero-Clark C; Youssof S
Neurogastroenterol Motil; 2018 Apr; 30(4):e13251. PubMed ID: 29144056
[TBL] [Abstract][Full Text] [Related]
5. Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population.
Côté C; Fortin J; Brais B; Youssof S; Gagnon C
Qual Life Res; 2022 Jan; 31(1):293-302. PubMed ID: 34292466
[TBL] [Abstract][Full Text] [Related]
6. The requirement for a disease-specific patient-reported outcome measure of dysphagia in oculopharyngeal muscular dystrophy.
Côté C; Gagnon C; Youssof S; sKurtz N; Brais B
Muscle Nerve; 2019 Apr; 59(4):445-450. PubMed ID: 30575974
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of cricopharyngeal myotomy in oculopharyngeal muscular dystrophy.
Coiffier L; Périé S; Laforêt P; Eymard B; St Guily JL
Otolaryngol Head Neck Surg; 2006 Aug; 135(2):218-22. PubMed ID: 16890071
[TBL] [Abstract][Full Text] [Related]
8. Dysphagia with fatal choking in oculopharyngeal muscular dystrophy: Case report.
Chen AW; Wu SL; Cheng WL; Chuang CS; Chen CH; Chen MK; Liu CS
Medicine (Baltimore); 2018 Oct; 97(43):e12935. PubMed ID: 30412104
[TBL] [Abstract][Full Text] [Related]
9. Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.
Youssof S; Schrader RM; Romero-Clark C; Roy G; Spafford M
Muscle Nerve; 2014 Apr; 49(4):601-3. PubMed ID: 24259282
[TBL] [Abstract][Full Text] [Related]
10. Utility of surgical myotomy in the dysphagia due to oculopharyngeal dystrophy.
Acosta Mérida Mª; Marchena Gómez J; Afonso Déniz JM
Rev Esp Enferm Dig; 2016 Dec; 108(12):843-844. PubMed ID: 27809552
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on upper esophageal sphincter dilatation for the treatment of dysphagia in patients with oculopharyngeal muscular dystrophy.
Mathieu J; Lapointe G; Brassard A; Tremblay C; Brais B; Rouleau GA; Bouchard JP
Neuromuscul Disord; 1997 Oct; 7 Suppl 1():S100-4. PubMed ID: 9392026
[TBL] [Abstract][Full Text] [Related]
12. Nutritional Risk in Oculopharyngeal Muscular Dystrophy: Beyond Dysphagia.
Forgues C; Fortin J; Gagnon C; Brisson JD; Mathieu J; Brais B; Côté C
Can J Diet Pract Res; 2021 Jun; 82(2):95-97. PubMed ID: 33876991
[No Abstract] [Full Text] [Related]
13. Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.
Périé S; Trollet C; Mouly V; Vanneaux V; Mamchaoui K; Bouazza B; Marolleau JP; Laforêt P; Chapon F; Eymard B; Butler-Browne G; Larghero J; St Guily JL
Mol Ther; 2014 Jan; 22(1):219-25. PubMed ID: 23831596
[TBL] [Abstract][Full Text] [Related]
14. Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument.
Youssof S; Romero-Clark C; Warner T; Plowman E
Muscle Nerve; 2017 Jul; 56(1):28-35. PubMed ID: 27759888
[TBL] [Abstract][Full Text] [Related]
15. Swallowing, Chewing and Speaking: Frequently Impaired in Oculopharyngeal Muscular Dystrophy.
Kroon RHMJM; Horlings CGC; de Swart BJM; van Engelen BGM; Kalf JG
J Neuromuscul Dis; 2020; 7(4):483-494. PubMed ID: 32804098
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trial.
Wu PI; Szczesniak MM; Maclean J; Graham PH; Quon H; Choo L; Cook IJ
Dis Esophagus; 2019 Jun; 32(6):. PubMed ID: 30462194
[TBL] [Abstract][Full Text] [Related]
18. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
[TBL] [Abstract][Full Text] [Related]
19. Aggressive bougie dilatation and intralesional steroids is effective in refractory benign esophageal strictures secondary to corrosive ingestion.
Nijhawan S; Udawat HP; Nagar P
Dis Esophagus; 2016 Nov; 29(8):1027-1031. PubMed ID: 26542391
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
Bae JS; Ki CS; Kim JW; Kim BJ
J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
